1. Home
  2. ARGX vs TRGP Comparison

ARGX vs TRGP Comparison

Compare ARGX & TRGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARGX
  • TRGP
  • Stock Information
  • Founded
  • ARGX 2008
  • TRGP 2005
  • Country
  • ARGX Netherlands
  • TRGP United States
  • Employees
  • ARGX N/A
  • TRGP N/A
  • Industry
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • TRGP Natural Gas Distribution
  • Sector
  • ARGX Health Care
  • TRGP Utilities
  • Exchange
  • ARGX Nasdaq
  • TRGP Nasdaq
  • Market Cap
  • ARGX 37.3B
  • TRGP 32.1B
  • IPO Year
  • ARGX 2017
  • TRGP 2010
  • Fundamental
  • Price
  • ARGX $623.82
  • TRGP $176.69
  • Analyst Decision
  • ARGX Strong Buy
  • TRGP Strong Buy
  • Analyst Count
  • ARGX 20
  • TRGP 16
  • Target Price
  • ARGX $634.50
  • TRGP $176.19
  • AVG Volume (30 Days)
  • ARGX 290.3K
  • TRGP 2.1M
  • Earning Date
  • ARGX 10-31-2024
  • TRGP 02-13-2025
  • Dividend Yield
  • ARGX N/A
  • TRGP 1.70%
  • EPS Growth
  • ARGX N/A
  • TRGP 44.82
  • EPS
  • ARGX N/A
  • TRGP 5.53
  • Revenue
  • ARGX $1,908,659,000.00
  • TRGP $16,215,700,000.00
  • Revenue This Year
  • ARGX $61.99
  • TRGP $13.40
  • Revenue Next Year
  • ARGX $42.48
  • TRGP $24.38
  • P/E Ratio
  • ARGX N/A
  • TRGP $31.96
  • Revenue Growth
  • ARGX 85.56
  • TRGP N/A
  • 52 Week Low
  • ARGX $349.86
  • TRGP $81.03
  • 52 Week High
  • ARGX $644.97
  • TRGP $209.87
  • Technical
  • Relative Strength Index (RSI)
  • ARGX 58.04
  • TRGP 38.71
  • Support Level
  • ARGX $613.95
  • TRGP $171.19
  • Resistance Level
  • ARGX $644.97
  • TRGP $187.46
  • Average True Range (ATR)
  • ARGX 14.33
  • TRGP 4.91
  • MACD
  • ARGX -0.42
  • TRGP -3.05
  • Stochastic Oscillator
  • ARGX 50.28
  • TRGP 19.46

About ARGX argenx SE

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

About TRGP Targa Resources Inc.

Targa Resources is a midstream firm that primarily operates gathering and processing assets with substantial positions in the Permian, Stack, Scoop, and Bakken plays. It has fractionation capacity at Mont Belvieu and operates a liquefied petroleum gas export terminal. The Grand Prix natural gas liquids pipeline is another important asset.

Share on Social Networks: